The prophylactic use of anti-arrhythmic drugs in acute myocardial infarction.
D000208:Acute Disease; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use* / Q000633:toxicity; D001145:Arrhythmias, Cardiac / Q000209:etiology / Q000401:mortality / Q000517:prevention & control*; D001285:Atropine / Q000627:therapeutic use; D001919:Bradycardia / Q000209:etiology / Q000517:prevention & control; D003645:Death, Sudden; D004562:Electrocardiography; D005260:Female; D006339:Heart Rate; D006801:Humans; D008012:Lidocaine / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications* / Q000188:drug therapy / Q000401:mortality; D011342:Procainamide / Q000627:therapeutic use; D013610:Tachycardia / Q000209:etiology / Q000517:prevention & control; D014693:Ventricular Fibrillation / Q000209:etiology / Q000517:prevention & control
D000889:Anti-Arrhythmia Agents; D001285:Atropine; D008012:Lidocaine; D011342:Procainamide